Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nupathe Inc. (PATH) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nupathe Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1375200.
Total stock buying since 2010: $3,850,895.
Total stock sales since 2010: $746,469.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 223,000 | $746,469 | 0 | $0 |
| 2011 | 37,500 | $96,755 | 0 | $0 | 0 | $0 |
| 2010 | 375,414 | $3,754,140 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-10 | 0 | $0 | 223,000 | $746,469 | 0 | $0 |
| 2011-09 | 37,500 | $96,755 | 0 | $0 | 0 | $0 |
| 2010-08 | 375,414 | $3,754,140 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-10-17 | Bioadvance Ventures L P (10% Owner) | Sale | 37,593 | 3.39 | 127,440 |
| 2012-10-16 | Bioadvance Ventures L P (10% Owner) | Sale | 72,407 | 3.29 | 238,219 |
| 2012-10-15 | Bioadvance Ventures L P (10% Owner) | Sale | 113,000 | 3.37 | 380,810 |
| 2011-09-15 | Roche Robert P Jr (Director) | Buy | 10,000 | 2.68 | 26,800 |
| 2011-09-09 | Hollingsworth Jane H (Chief Executive Officer) | Buy | 20,000 | 2.56 | 51,280 |
| 2011-09-07 | Kurtzman Gary J (Director) | Buy | 7,500 | 2.49 | 18,675 |
| 2010-08-11 | Ivp Gp, Llc (10% Owner) | Buy | 293,590 | 10.00 | 2,935,900 |
| 2010-08-11 | Birchmere Ventures Iii Tsib Lp (Other) | Buy | 27,066 | 10.00 | 270,660 |
| 2010-08-11 | Birchmere Ventures Iii Lp (Other) | Buy | 54,758 | 10.00 | 547,580 |
Insider trading activities including stock purchases, stock sales, and option exercises of PATH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nupathe Inc. (symbol PATH, CIK number 1375200) see the Securities and Exchange Commission (SEC) website.